Healthcare - Page 279 | TalkMarkets

Content

All Posts > Content under Healthcare
4449 to 4464 of 8479 Posts
<<< 1 ... 277 278 279 280 281 ... 530 >>>
Quest Diagnostics Poised On Solid Q1 Results Despite Woes
Article By: Zacks Investment Research
Monday, May 22, 2017 10:57 AM EDT
Quest expects revenue growth for the period 2017–2020 to be 3–5%. Earnings for the same period are expected to grow faster than revenues in the mid-to-high single digit range.
In this article: DGX Also: BAX, ALGN, HOLX
Read
Premarket Biotech Digest – AMGN Announces Positive Results, FOLD Completes Analysis Plan, JNJ Files Lawsuit
Article By: KKD Healthcare Analytics
Monday, May 22, 2017 9:41 AM EDT
Amgen Inc. announced that it has received positive results from a Phase 3 clinical trial. AstraZeneca announced selling the European rights to its aging beta-blocker heart drug Seloken to Italian company Recordati.
In this article: AZN, BMY, JNJ, FOLD, AMGN, MYL, INSM, GBSN
Read
GlycoMimetics Surges 100% On Breakthrough Therapy Designation
Article By: Terry Chrisomalis
Sunday, May 21, 2017 11:52 PM EDT
On Thursday, GlycoMimetics surged as high 100% after the company announced that it had received FDA breakthrough therapy designation.
In this article: GLYC
Read
Week In Review: Shanghai Pharma Considers $4 Billion Bid For Germany's Stada
Article By: ChinaBio® Today
Saturday, May 20, 2017 11:46 AM EDT
Shanghai Pharma may bid $4 billion to acquire Stada Arzneimittel, a German generic drugmaker. Stada has already accepted a similar offer from a consortium formed by two private equity firms -- Bain and Cinven.
In this article: AZN, LLY
Read
Argenx Joins Nasdaq Parade Following G1 Therapeutics With Another IPO Success
Article By: Lorimer Wilson
Thursday, May 18, 2017 5:45 PM EDT
Today's IPO by Argenx SE has proven to be a success as it was up 35% at the close of the trading day.Yesterday's IPO by G1 Therapeutics was also a success closing the day up 10.67% above its initial price.
In this article: ARGX Also: VRNA, ZYME, URGN, BHVN
Read
4 Large-Cap Drug Stocks To Buy Post Q1 Earnings
Article By: Sweta Killa
Thursday, May 18, 2017 3:20 PM EDT
The Medical sector is among the sectors that has consistently been recording earnings growth over the last few quarters. The sector, which had recorded earnings growth of 4.5% on revenue growth of 5.2% in Q4.
In this article: MRK, BAYRY, HLUYY, ZTS
Read
Repros Announces Pricing Of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, May 18, 2017 3:12 PM EDT
Repros Therapeutics Inc., announced today that it has entered into an underwriting agreement to sell in a public offering 2,744,125 shares of the Company’s common stock.
In this article: RPRX
Read
Hot Options Report For Midday - Thursday, May 18
Article By: The Options Insider
Thursday, May 18, 2017 2:20 PM EDT
Hot options for midday: KGC, PFE, AAPL, P, AMD, BABA, BAC and T.
In this article: KGC, PFE, AAPL, P, AMD, BABA, T, BAC
Read
Shire Ltd.'s $6 Billion Bet On Drug For Hereditary Angioedema Pays Off With Stellar Phase III Data
Article By: Lorimer Wilson
Thursday, May 18, 2017 1:54 PM EDT
Shire Ltd. bought Dyax for $6 billion in 2015 for its new drug for hereditary angioedema. Shire CEO Flemming Ornskov says their multi-billion dollar bet paid off with stellar Phase III data for the drug, now called lanadelumab.
In this article: SHPG
Read
Endologix, Inc. Shares Dip Down On Update On Nellix Timetable To Get To US Market
Article By: TickerTV
Thursday, May 18, 2017 11:35 AM EDT
ELGX opened trading yesterday at $6.69 which was down from the previous day’s trading close of $6.80. Shares closed trading yesterday at $6.73 and spiked down after the market closed to $5.50, equivalent to an 18% decrease from the closing price.
In this article: ELGX
Read
The Active Versus Passive Performance Debate Is Nonsensical
Article By: Chuck Carnevale
Thursday, May 18, 2017 10:23 AM EDT
One of the most hotly contested debates in finance is the argument over which is better – active or passive investing.
In this article: KMB, SPX, SO, JNJ
Read
Small Cap Best And Worst Stocks - Thursday, May 18
Article By: E.B. Capital Markets
Thursday, May 18, 2017 7:37 AM EDT
The average small cap score is 48.99 and the average score over the past four weeks is 49.99.
In this article: ELLI, EVC, MNTA, ASTE, CNMD, ICUI, KTOS, MMSI, WRLD, DCTH
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly
Wednesday, May 17, 2017 9:48 PM EDT
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read
UnitedHealth Dip After U.S. Joins Lawsuit Seen As Buying Opportunity
Article By: The Fly
Wednesday, May 17, 2017 12:17 PM EDT
After the Justice Department joined a lawsuit seeking over $1B from health insurer UnitedHealth yesterday and the company's stock fell in the wake of the news, two research firms recommended buying the stock on the pullback.
In this article: UNH Also: AET, CNC, CI, HUM
Read
The Market For US Prescription Drugs
Article By: Timothy Taylor
Wednesday, May 17, 2017 10:09 AM EDT
Brand-name manufacturers often find ways to push back competition from generics, and when a generic for a relatively rare condition has a monopoly, the price for the generic skyrockets, too.
In this article: CVS, WBA, ESRX, WMT
Read
Mid Cap Best And Worst Stocks - Wednesday, May 17
Article By: E.B. Capital Markets
Wednesday, May 17, 2017 9:24 AM EDT
The average score for mid cap stocks in our universe is 54.99 and the average score over the past four weeks is 56.65.
In this article: CBT, EAT, NNN, OPK, PKI, TNH, ALGN, ABCO, CDNS, CLVS
Read
4449 to 4464 of 8479 Posts
<<< 1 ... 277 278 279 280 281 ... 530 >>>